Beond Ibogaine Inc

What Beond Ibogaine Inc does

Beond Ibogaine Inc is a privately held medical services company that operates a medically supervised ibogaine treatment facility in Cancun, Mexico, and has treated over 3,000 patients cumulatively. The company delivers treatment through a proprietary 5-phase neurorestorative program (preparation, onsite pre-treatment, neuroplasticity treatment, acute aftercare, and long-term aftercare) using ibogaine, an alkaloid derived from the Tabernanthe iboga plant, combined with hospital-grade clinical infrastructure including advanced cardiac monitoring, ICU-certified nursing staff, and rigorous pre-admission medical screening. The core target population includes individuals with chemical dependency (opioids, fentanyl, alcohol, stimulants), behavioral addictions, PTSD, traumatic brain injury, depression, and anxiety, with a separate optimization track for high-functioning individuals seeking personal growth.

The business model is direct-to-consumer, cash-pay, with tiered per-treatment pricing of $12,500 (90+ day early commitment), $15,500 (standard), and $19,500 (premium/shorter notice), including all preparation, treatment, accommodations, and aftercare. A 7-day Transitions Program is offered at $15,500 for non-symptomatic individuals. Revenue is generated entirely through treatment fees; no insurance reimbursement or enterprise contracts are disclosed. The company operates sub-brands including Beond Service (veterans and first responders), Beond Black (private retreats), Beond Research (clinical research division), and Beond the Beach (hospitality). Distribution is direct via consultation-based outreach, with marketing concentrated on earned media (Joe Rogan Experience, Washington Post, Forbes), the Ibogaine Uncovered podcast, and organic social channels.

Beond is currently expanding its U.S. footprint through a planned Austin, Texas center to handle education, pre-treatment preparation, and post-treatment aftercare, and is actively supporting regulatory initiatives including Texas HB3717, which committed $50 million in state funding to ibogaine research. The company partners with Blessings of the Forest in Gabon for ethical iboga sourcing and with Forward Intent and Born Primitive for veteran/first responder outreach. No institutional funding rounds, headcount figures, or revenue figures are disclosed in the available data.

Name

Beond Ibogaine Inc

Legal name

Beond Ibogaine Inc

Website

https://www.beondibogaine.com

Company type

Private

Operating status

Operating

Short description

Beond Ibogaine Inc operates a medically supervised ibogaine treatment center in Cancun, Mexico, serving individuals with addiction, PTSD, TBI, depression, and anxiety through a proprietary 5-phase neurorestorative program, with over 3,000 patients treated and expansion planned to Austin, Texas.

Ownership category

akta.pro rank

Product category

Psychedelic Medicine Treatment Services

NAICS

Residential Mental Health and Substance Abuse Facilities (623220), Residential Mental Health and Substance Abuse Facilities (62322)

SIC

Services-Nursing & Personal Care Facilities (8050)

akta.pro primary industry

Residential Substance Use Rehabilitation (Inpatient Rehab) (HLAFACAE)

akta.pro secondary industry

Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF)

Keywords

• Ibogaine treatment services
• Psychedelic medicine therapy
• Addiction recovery treatment
• Neuroplasticity-based therapy
• PTSD and trauma treatment

Headquarters

HQ city

Cancún

HQ country

Mexico

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain, Technology or R&D

Revenue model

1. Ibogaine Treatment Services: One-time treatment program fees with tiered pricing based on commitment timing. The company offers a complete therapeutic care program starting at $12,500 for early commitments (90+ days in advance), with standard pricing at $15,500 and premium pricing at $19,500 for shorter-notice bookings. Average program length is 10 days with possible extensions at pro-rated cost. Includes all remote preparation coaching, nutritional support, adjunct therapies, holistic medical care, acute and remote long-term aftercare support, accommodations, and private ground transportation.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels9 records

Core offering

Beond operates a medically supervised ibogaine treatment center in Cancun, Mexico, delivering a proprietary 5-phase neurorestorative program that combines hospital-grade clinical care, advanced cardiac monitoring, and ICU-certified nursing with ibogaine-assisted neuroplasticity therapy. Treatment spans approximately 10 days and addresses chemical dependency, behavioral addiction, mood disorders, PTSD, TBI, and peak performance optimization, with structured preparation and long-term aftercare coaching.

Product overview

Beond Ibogaine Inc operates a single-site ibogaine treatment center in Cancun, Mexico, offering medically supervised neuroplasticity medicine through a proprietary 5-phase neurorestorative program. The core offering is the Beond Ibogaine Treatment Program, which encompasses specialized treatment tracks for Mood/Trauma/PTSD, Chemical Dependency/Behavioral Addiction, and Personal Growth/Peak Performance. The company also operates a dedicated sub-brand, Beond Service, focused on veterans, first responders, and their families. Additional offerings include a Transitions Program for optimization without clinical dependency, therapeutic coaching services, and private retreats under the Beond Black brand. All programs integrate ibogaine-assisted therapy with hospital-grade clinical care, preparation coaching, and structured aftercare support.

Differentiator

Problem solved

Functional benefit

Brands

• Beond Service: A data-driven neuroplasticity and mental health optimization program designed specifically for veterans, first responders, and their families, integrating clinical care, coaching, and ibogaine treatment.
• Beond Black
• Beond Research
• Beond the Beach

Products and services

• Beond Ibogaine Treatment Program Medically supervised ibogaine treatment combined with hospital-grade clinical care, delivered at a facility in Cancun, Mexico. The core neuroplasticity medicine program encompasses the entire care continuum from preparation through longer-term aftercare using a proprietary 5-phase model, and is intended for adults seeking treatment for addiction, trauma, mood disorders, or cognitive optimization.
• Mood, Trauma & PTSD Treatment Program Neuroplasticity-focused clinical program utilizing medically supervised ibogaine treatment to restore adaptive neural function and emotional safety for individuals with PTSD, traumatic brain injury, depression, and anxiety.
• Chemical Dependency & Behavioral Addiction Program Neuroplasticity-focused clinical program designed to interrupt maladaptive reward and stress pathways and support long-term recovery from substance addictions (including Fentanyl, opioids, alcohol, stimulants, prescription medications) and behavioral patterns such as gambling, digital dependency, eating disorders, and pornography use.
• Personal Growth and Peak Performance Program Neuroplasticity-focused clinical program for high-functioning individuals seeking cognitive clarity, emotional regulation, nervous system optimization, and personal or psycho-spiritual development over a 7-10 day immersive experience.
• Beond Service Data-driven neuroplasticity and mental health optimization program designed specifically for U.S. veterans, first responders, and their families, integrating clinical care, structured coaching, group-based work, and data-informed insights with ibogaine treatment as a catalyst.
• Transitions Program 7-day specialized ibogaine program for individuals not experiencing mood disorder or chemical dependency symptoms, focused on psycho-spiritual growth and optimization of life skills, with specific clinical pre-qualification requirements and $15,500 pricing.
• Therapeutic Coaching Guided support including therapeutic workshops, preparation coaching, and integration coaching to help individuals develop robust, individualized aftercare plans and maintain recovery goals before and after the on-site ibogaine treatment.
• Beond Black Private Retreats Private, exclusive retreat offering under the Beond Black brand for personalized ibogaine experiences, operated at a separate URL.
• 5-Phase Neurorestorative Program Proprietary treatment framework encompassing Preparation (remote coaching), Onsite Pre-treatment (medical assessment), Neuroplasticity Treatment (ibogaine with cardiac monitoring), Acute Aftercare (integration), and Long-term Aftercare (ongoing support), forming the structural backbone of all Beond offerings.

Quantifiable outcome

• 88% reduction in PTSD symptoms among veteran participants
• +4 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Born PrimitivecoreGTM or Marketing Partner · 5 May 2025Veteran-owned apparel and footwear brand partnering with Beond Service to fund life-changing ibogaine treatment for veterans, first responders, and their spouses. Through sale of limited-edition campaign shirts, 100% of profits directly fund treatment for those healing from PTSD, trauma, and substance use disorders. Partnership announced May 5, 2025, timed for Memorial Day.
• Forward IntentcoreGTM or Marketing PartnerKey partner supporting innovative access for the veteran and first responder community to programs like Beond Service, helping expand reach and impact where it's needed most. Forward Intent is described as a key partner in the Beond Service partnership ecosystem focused on improving cognitive function, mental health, and long-term outcomes.
• Blessings of the Forest (BOTF)coreStrategic or Co-development PartnerNonprofit organization in Gabon dedicated to preserving, researching, and sharing knowledge about Gabonese forest traditions. Beond partners with BOTF for ethical iboga sourcing, committing to plant three iboga trees in Gabon for each treatment administered. BOTF works to conserve iboga, restore ethical access, and ensure Gabonese communities who are original stewards of the medicine are at the forefront of its future.
• REID Foundation / American Ibogaine InitiativecoreStrategic or Co-development PartnerLed by W. Bryan Hubbard, the first Chairman of the Kentucky Opioid Commission, the REID Foundation spearheads the American Ibogaine Initiative. Beond has worked alongside this foundation in advocacy efforts and policy development, including supporting Texas legislation (HB3717) that committed $50 million to ibogaine research.
• Texas Ibogaine InitiativecoreStrategic or Co-development PartnerCoalition working on Texas legislation to fund ibogaine research. Beond has supported this initiative as a global leader in medically supervised ibogaine treatment, contributing data on safety and patient results to newly funded clinical trials. Texas HB3717 commits $50 million to FDA-approved clinical trials.
• TerraGnosisminorStrategic or Co-development PartnerInternational organization that partnered with Blessings of the Forest to become the first international organization to gain ethical access to iboga through a Gabonese community, fully compliant with the Nagoya Protocol. Related to but distinct from Beond's direct partnership with BOTF.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Emerging players

• Compass Pathways: Public clinical-stage company developing psilocybin therapy for treatment-resistant depression. Comparable as a psychedelic-medicine operator in the same mental health and addiction indication space, though focused on psilocybin and a clinical-trial/partnered distribution model rather than direct-to-consumer treatment.
• ATAI Life Sciences: Clinical-stage biopharmaceutical platform company focused on psychedelic and non-psychedelic therapies for mental health, including addiction. A peer in the psychedelic treatment-development category targeting overlapping patient populations.
• MindMed (Mind Medicine): Clinical-stage psychedelic medicine company developing ibogaine and other psychedelic-derived therapies for mental health and addiction. A more drug-development-focused peer, but pursuing the same underlying indication space as Beond.
• Field Trip Health: Operator of psychedelic-assisted psychotherapy clinics (primarily ketamine) in North America targeting depression, anxiety, and PTSD. Comparable business model — medically supervised psychedelic treatment in retreat-style clinics — though focused on ketamine rather than ibogaine.

Broad incumbents

• Hazelden Betty Ford Foundation: Large US nonprofit residential addiction treatment provider operating inpatient rehab facilities nationwide. Comparable as a residential substance use disorder treatment operator at scale, though using traditional evidence-based modalities rather than ibogaine.
• Caron Treatment Centers: Established US residential addiction and behavioral health treatment provider serving a similar patient demographic (substance use, co-occurring mental health). Comparable as an incumbent in the residential rehab category targeting the same clinical indications Beond addresses.

Direct peers

• Ambio Life Sciences: Ibogaine treatment center operating in Mexico with a medical-model approach to ibogaine therapy for addiction and mental health. Closely comparable to Beond in service offering, geography, and patient mix.
• Experience Ibogaine Treatment Center: One of the most established Mexico-based ibogaine clinics offering medically supervised ibogaine treatment for addiction and mental health. Directly competes with Beond in Cancun-area destination treatment, with similar target customers and treatment model.
• Ibogaine by David Dardashti: Long-running ibogaine treatment provider offering medically supervised ibogaine therapy, primarily for opioid and substance use disorders. Operates a similar destination-clinic model targeting US patients seeking ibogaine outside the US regulatory framework.
• Ketamine Wellness Centers: US-based outpatient ketamine infusion provider treating depression, PTSD, and chronic pain. Comparable as a medically supervised psychedelic-adjacent treatment clinic with similar patient mix (treatment-resistant mood and trauma) but operating domestically and using ketamine rather than ibogaine.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@beondibogaine
• Facebookfacebook.com/beondibogaine
• Instagraminstagram.com/beond.us
• TikToktiktok.com/@beond.us

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beond Ibogaine Inc